Intelligence Platform
Patents
Browse 13 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11932852
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted patentUS 11535851
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
granted patentUS 11234994
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted patentUS 11142765
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted patentUS 10898505
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
granted patentUS 10000753
Age-related macular degeneration treatment
granted patentUS 9518260
Pain treatment
granted patentUS 9410154
HBV treatment
granted patentUS 9080174
HBV treatment
granted patentUS 8691967
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
granted patentUS 8283461
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
granted patentUS 8129510
Minigene expression cassette
granted patentUS 7727970
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted t
granted